Host genomic HIV restriction factors modulate the response to dendritic cell-based treatment against HIV-1

Pontillo, Alessandra; Da Silva, Ronaldo C.; Moura, Ronald; Crovella, Sergio
February 2014
Human Vaccines & Immunotherapeutics;Feb2014, Vol. 10 Issue 2, p1
Academic Journal
No abstract available.


Related Articles

  • Influence of Dendritic Cells on B-Cell Responses during HIV Infection. Poudrier, Johanne; Chagnon-Choquet, Josiane; Roger, Michel // Clinical & Developmental Immunology;2012, p1 

    Dendritic cells (DCs) modulate B-cell differentiation, activation, and survival mainly through production of growth factors such as B lymphocyte stimulator (BLyS/BAFF). DC populations have been reported to be affected in number, phenotype and function during HIV infection and such alterations...

  • Monocyte and Myeloid Dendritic Cell Activation Occurs Throughout HIV Type 2 Infection, an Attenuated Form of HIV Disease. Cavaleiro, Rita; Tendeiro, Rita; Foxall, Russell B.; Soares, Rui S.; Baptista, António P.; Gomes, Perpétua; Valadas, Emília; Victorino, Rui M. M.; Sousa, Ana E. // Journal of Infectious Diseases;Jun2013, Vol. 207 Issue 11, p1730 

    Monocytes and myeloid dendritic cells (mDCs) are important orchestrators of innate and human immunodeficiency virus (HIV)–specific immune responses and of the generalized inflammation that characterizes AIDS progression. To our knowledge, we are the first to investigate monocyte and mDC...

  • Methamphetamine Modulates Gene Expression Patterns in Monocyte Derived Mature Dendritic Cells. Mahajan, Supriya D.; Zihua Hu; Reynolds, Jessica L.; Aalinkeel, Ravikumar; Schwartz, Stanley A.; Nair, Madhavan P. N. // Molecular Diagnosis & Therapy;Jul2006, Vol. 10 Issue 4, p257 

    Background: The US is currently experiencing a grave epidemic of methamphetamine use as a recreational drug, and the risk for HIV-1 infection attributable to methamphetamine use continues to increase. Recent studies show a high prevalence of HIV infection among methamphetamine users. Dendritic...

  • miRNA-1236 Inhibits HIV-1 Infection of Monocytes by Repressing Translation of Cellular Factor VprBP. Ma, Li; Shen, Chan-Juan; Cohen, Éric A.; Xiong, Si-Dong; Wang, Jian-Hua // PLoS ONE;Jun2014, Vol. 9 Issue 6, p1 

    Primary monocytes are refractory to HIV-1 infection and become permissive upon differentiation into monocyte-derived dendritic cells (MDDCs) or macrophages. Multiple mechanisms have been proposed to interpret HIV-1 restriction in monocytes. Human cellular miRNAs can modulate HIV-1 infection by...

  • Dynamics of Virus-Host Interplay in HIV-1 Replication. Sorin, Masha; Kalpana, Ganjam V. // Current HIV Research;Apr2006, Vol. 4 Issue 2, p117 

    HIV-1, the causative agent of AIDS, is an obligate intracellular parasite that has both evolved to invade the complex human system and adapted to utilize the host machinery for its own propagation. A dynamic interaction between the virus and the host systems can be observed at every step of...

  • Tetherin does not significantly restrict dendritic cell-mediated HIV-1 transmission and its expression is upregulated by newly synthesized HIV-1 Nef. Coleman, Christopher M.; Spearman, Paul; Li Wu // Retrovirology;2011, Vol. 8 Issue 1, p26 

    Background: Dendritic cells (DCs) are among the first cells to encounter HIV-1 and play important roles in viral transmission and pathogenesis. Immature DCs allow productive HIV-1 replication and long-term viral dissemination. The pro-inflammatory factor lipopolysaccharide (LPS) induces DC...

  • Analysis of Host Gene Expression Profile in HIV-1 and HIV-2 Infected T-Cells. Devadas, Krishnakumar; Biswas, Santanu; Haleyurgirisetty, Mohan; Wood, Owen; Ragupathy, Viswanath; Lee, Sherwin; Hewlett, Indira // PLoS ONE;1/28/2016, Vol. 11 Issue 1, p1 

    HIV replication is closely regulated by a complex pathway of host factors, many of them being determinants of cell tropism and host susceptibility to HIV infection. These host factors are known to exert a positive or negative influence on the replication of the two major types of HIV, HIV-1 and...

  • Reply to “Calcium-modulating cyclophilin ligand does not restrict retrovirus release”. Varthakavi, Vasundhara; Heimann-Nichols, Ellen; Smith, Rita M.; Rose, Jeremy // Nature Medicine;Feb2010, Vol. 16 Issue 2, p157 

    A response by Vasundhara Varthakavi, Ellen Heimann-Nichols, Rita M. Smith and Jeremy Rose to a letter to the editor about their article on the use of calcium-modulating cyclophilin ligand (CAML) as a host restriction factor that blocks HIV-1 release in volume 16, 2010 issue is presented.

  • APOBEC3G & HTLV-1: Inhibition without deamination. Strebel, Klaus // Retrovirology;2005, Vol. 2, p37 

    APOBEC3G is a cellular cytidine deaminase that was recently identified as the Vif-sensitive antiviral host factor responsible for the restriction of vif-defective HIV-1 in primary human cells and certain non-permissive T cell lines. Inhibition of HIV-1 replication is thought to be the result of...

  • Identification of calcium-modulating cyclophilin ligand as a human host restriction to HIV-1 release overcome by Vpu. Varthakavi, Vasundhara; Heimann-Nichols, Ellen; Smith, Rita M.; Sun, Yuehui; Bram, Richard J.; Ali, Showkat; Rose, Jeremy; Ding, Lingmei; Spearman, Paul // Nature Medicine;Jun2008, Vol. 14 Issue 6, p641 

    The HIV-1 Vpu protein is required for efficient viral release from human cells. For HIV-2, the envelope (Env) protein replaces the role of Vpu. Both Vpu and HIV-2 Env enhance virus release by counteracting an innate host-cell block within human cells that is absent in African green monkey (AGM)...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics